Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Schaverien, Mark V

University Of Tx Md Anderson Can Ctr
United States

Lymphedema Prevention Through Immediate Lymphatic Reconstruction 5R01CA292908-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J

Oregon Health & Science University
United States

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention 5R01CA169175-11 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schenker, Yael

University Of Pittsburgh At Pittsburgh
United States

Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial 5R01CA235730-06 Brennan Streck, Ph.D., RN, M.P.H.
Schmidt, Christian Maximillian

Indiana University Indianapolis
United States

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer 5U01CA239522-05 Claire Zhu, Ph.D.
Schmit, Stephanie L.

Cleveland Clinic Lerner Com-Cwru
United States

Variation in tumor-associated immune profiles and colorectal cancer outcomes 5R01CA248931-05 Asad Umar, D.V.M., Ph.D.
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

Blood-Based Testing for Advanced Adenoma 5U01CA271884-04 Matthew Young, Ph.D.
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

Blood-Based Testing for Advanced Adenoma 5U01CA271884-04 Matthew Young, Ph.D.
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 5R37CA275916-03 Claire Zhu, Ph.D.
Schuetze, Scott Michael

University Of Michigan At Ann Arbor
United States

Early Phase Clinical Cancer Prevention Consortium 2UG1CA242632-06 Donald Johnsey
Sears, Rosalie C

Oregon Health & Science University
United States

An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals 4U01CA294548-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sears, Rosalie C

Oregon Health & Science University
United States

Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs 5U01CA278923-03 Matthew Young, Ph.D.
Sedrak, Mina S

University Of California Los Angeles
United States

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H.
Sedrak, Mina S

University Of California Los Angeles
United States

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H.
Segal, Leopoldo Nicolas

New York University School Of Medicine
United States

Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer 5U2CCA271890-03 Guillermo Marquez, Ph.D.
Segata, Nicola

University Of Trento
United States

PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS) 1OT2CA297205-01 Asad Umar, D.V.M., Ph.D.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials